Pablo Cabral is the Executive Director of External Innovation at Eli Lilly, a position they have held since 2025, after serving as Senior Director of the same department starting in 2023. Prior to joining Eli Lilly, Pablo worked as a Principal Scientist at The Janssen Pharmaceutical Companies of Johnson & Johnson from 2021 to 2023 and as an Associate Principal Scientist at Merck from 2017 to 2021. Pablo has also made significant contributions in kidney regeneration research as a Senior Scientist at Miromatrix Medical Inc. from 2015 to 2017. Their academic background includes a medical degree from Universidad Nacional de Córdoba, which they are currently pursuing.
This person is not in the org chart
This person is not in any teams
This person is not in any offices